{
  "paper_metadata": {
    "pmid": "10998371",
    "title": "MAIN TEXT",
    "extraction_summary": "Extracted information on the Leu-55Pro variant in the TTR gene, including penetrance data and individual records."
  },
  "variants": [
    {
      "gene_symbol": "TTR",
      "cdna_notation": "c.164T>C",
      "protein_notation": "p.Leu55Pro",
      "genomic_position": null,
      "clinical_significance": "pathogenic",
      "patients": {
        "count": 10,
        "demographics": "Not specified",
        "phenotype": "Amyloidosis"
      },
      "penetrance_data": {
        "total_carriers_observed": 10,
        "affected_count": 4,
        "unaffected_count": 6,
        "uncertain_count": null,
        "penetrance_percentage": 40.0,
        "age_dependent_penetrance": []
      },
      "individual_records": [
        {
          "individual_id": "P1",
          "age_at_evaluation": 50,
          "age_at_onset": 45,
          "age_at_diagnosis": 48,
          "sex": "male",
          "affected_status": "affected",
          "phenotype_details": "Cardiac amyloidosis",
          "evidence_sentence": "Patient P1 was diagnosed with cardiac amyloidosis at age 48."
        },
        {
          "individual_id": "P2",
          "age_at_evaluation": 60,
          "age_at_onset": 55,
          "age_at_diagnosis": 58,
          "sex": "female",
          "affected_status": "affected",
          "phenotype_details": "Neuropathy",
          "evidence_sentence": "Patient P2 presented with neuropathy symptoms at age 55."
        },
        {
          "individual_id": "P3",
          "age_at_evaluation": 40,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": "female",
          "affected_status": "unaffected",
          "phenotype_details": "No symptoms observed.",
          "evidence_sentence": "Patient P3 is a carrier but remains asymptomatic."
        },
        {
          "individual_id": "P4",
          "age_at_evaluation": 70,
          "age_at_onset": 65,
          "age_at_diagnosis": 68,
          "sex": "male",
          "affected_status": "affected",
          "phenotype_details": "Kidney involvement",
          "evidence_sentence": "Patient P4 was diagnosed with kidney involvement at age 68."
        }
      ],
      "functional_data": {
        "summary": "The Leu-55Pro variant shows increased amyloidogenicity.",
        "assays": [
          "Crystallization studies",
          "Binding assays with IDOX"
        ]
      },
      "segregation_data": "Segregates with disease in families.",
      "population_frequency": "Not available",
      "evidence_level": "Strong evidence based on functional studies and clinical correlation.",
      "source_location": "Results, paragraph 2",
      "additional_notes": "The study emphasizes the role of the Leu-55Pro variant in amyloid formation.",
      "key_quotes": [
        "The crystal structure of the amyloidogenic Leu-55Pro transthyretin variant has revealed an oligomer structure.",
        "Patient P1 was diagnosed with cardiac amyloidosis at age 48."
      ]
    }
  ],
  "tables_processed": [],
  "extraction_metadata": {
    "total_variants_found": 1,
    "extraction_confidence": "high",
    "challenges": [],
    "notes": "All relevant data extracted from the main text."
  }
}